CALL US: 1-352-733-0111

A randomised, double blind, cross-over trial comparing the safety and efficacy of insulin degludec and insulin glargine, both with insulin aspart as mealtime insulin in subjects with type 1 diabetes


The overall purpose of this trial is to evaluate the hypoglycaemia profile of IDeg in subjects with T1DM currently treated with basal-bolus insulin therapy. Primary Objective: To compare the rates of severe or blood glucose confirmed symptomatic hypoglycaemia of IDeg once daily + IAsp to IGlar OD + IAsp, by demonstrating that the upper limit of the 95 percent confidence interval of the ratio is below or equal to a non-inferiority margin of 1.10, and if confirmed to a superiority limit of 1.0.


insulin, glargine, degludec, type 1 diabetes, hypoglycaemia

Principal Investigator

Mae Sheikh-Ali



Contact Information

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at

Other Resources

  • Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams